Vascular Biogenics

Related by string. * VASCULAR . vascular : cardio vascular . Cardio Vascular . peripheral vascular disease . peripheral vascular . vascular disrupting agent . Vascular . vascular disruption . VEGF Vascular Endothelial Growth / biogenic : biogenic amines . biogenic experimentation . biogenic amine . biogenic emissions . biogenic amines occur . Biogenic . biogenic methane . Biogenics * *

Related by context. Frequent words. (Click for all words.) 63 IIROC Halt 62 Bioventures 62 Mitsui Ventures 59 BioVentures 59 Exploit collaboration 59 Joins OTCQX 59 Files Shelf Registration Statement 58 IIROC Resume 58 Announces Non Brokered 58 Procognia 58 Shareholders Approve Acquisition 58 optical biosensors 58 Provides Shareholder 57 Completes Financing 57 AXYS Design Automation 57 Announces Immediate Availability 57 Jumps Higher 57 Geekzone ® SohoSolutions 57 Idera Pharmaceuticals 57 bio therapeutics 57 Lifesciences 57 Attracting Bullish Investors 57 Declares Dividend Quick Facts 57 Presents Positive 57 Finalizes Acquisition 56 Guides FY# Update 56 OncoMed Pharmaceuticals 56 BioSciences 56 Welcomes Analyst Initiation 56 Expands Portfolio 56 SomaLogic 56 Q3 Loss Narrows 56 Bayhill Therapeutics 56 Grants Options 56 Completes Merger 56 Increases Ownership 56 Enters Into Definitive Agreement 56 Makes Bearish 56 Closes Private Placement 56 Inpharmatica 56 Secures Additional 56 ImmunoCellular Therapeutics 55 Breda Netherlands 55 Earnings Postmortem 55 Puts Purchased 55 topically delivered 55 Inc Therapeutic Competitors 55 VP Exercises Options 55 Closes Acquisition Of 55 Guides FY# Quick Facts 55 Closes Financing 55 Therapeutic Competitors 55 Enters Into Letter 55 Vivecon 55 Introduces Revolutionary 55 Analytics announces 55 Completes Private Placement 55 Calls Purchased 55 Signs License Agreement 54 Equipment Deals 54 Zelos Therapeutics 54 Chiral Quest 54 gets USFDA nod 54 Miscellaneous #.#.# Release 54 please visit http:/www.stockguru.com 54 MorphoSys AG FSE MOR 54 Q1 Loss Narrows 54 Giza Venture 54 Q2 Loss Widens 54 Signs Joint Venture 54 Capital Invests 54 Pharmatech 54 BioSystems 54 Q2 Loss Narrows 54 ARM Embedded 54 Announces FDA Clearance 54 FY# Profit Rises 54 Quark Pharmaceuticals 54 BioWisdom 54 Director Exercises Options 54 Stock Downgraded 54 Synchron 54 TransTech Pharma 54 Product Pipeline 53 Agios Pharmaceuticals 53 Biocompatibles International 53 LifeSciences 53 Enters Into Strategic 53 Closes Acquisition 53 Perlegen Sciences 53 Ironwood Pharmaceuticals 53 Canada Trading Halt 53 Neurotech 53 Guides Inline 53 Q1 Profit Surges 53 Technolgies 53 Venture Financing 53 Vaccinex 53 Trius Therapeutics 53 Adopts Shareholder Rights 53 Bearish Pressure Building

Back to home page